Quote | Super Quote
Super Quote   |   Detail Quote   |   Interactive Chart   |   Transaction   |   Related News   |   Related Securities   |   Company Information   |   Dividend Records   |   Short Sell
06978 IMMUNOTECH-B
RT Nominal up2.740 +0.020 (+0.735%)
Shareholder's Disclosure of Interests
Disclosure of Interest   ｜   Fund Raising   ｜   Share Repurchase
Date Shareholder name Reason of Disclosure Buy/Sell and
Involved Shares		 Average Price per share Current Holdings % of Issued Shares
12/11/2025China Resources Company Limited1213(L)148,136,971(L)23.99
12/11/2025Tan Zheng Ltd1711(L)-22,765,714(L)157,714,286(L)30.65
12/11/2025Tan Zheng1711(L)-22,765,714(L)162,714,286(L)31.62
12/11/20251213(L)96,678,571(L)15.66
20/10/2025China Resources Pharmaceutical Group Limited1206(L)-29,627,394(L)148,136,971(L)28.79
20/10/2025China Resources Company Limited1206(L)-29,627,394(L)148,136,971(L)28.79
20/10/20251206(L)-19,335,714(L)96,678,571(L)18.79
20/10/20251206(L)-19,335,714(L)96,678,571(L)18.79
20/10/2025Tasly (Hong Kong) Pharmaceutical Investment Limited1206(L)-19,335,714(L)96,678,571(L)18.79
20/10/20251206(L)-19,335,714(L)96,678,571(L)18.79
18/09/2025Maxa Asset Management Limited1013(L)+123,135,430(L)123,135,430(L)19.31
18/09/2025Maxa Financial Group Limited1013(L)+123,135,430(L)123,135,430(L)19.31
18/09/2025Maxa Financial Group Holdings Limited1013(L)+123,135,430(L)123,135,430(L)19.31
18/09/2025Fok Chi Tat, Michael1013(L)+123,135,430(L)123,135,430(L)19.31
18/09/2025Cheung Siu Kai1013(L)+123,135,430(L)123,135,430(L)19.31
10/09/2025Evodevo Ltd1213(L)-50,000(L)30,823,000(L)5.99
10/09/2025JUNG Hyun Chul1213(L)-50,000(L)30,823,000(L)5.99
28/08/2025JUNG Hyun Chul1213(L)-3,291,000(L)35,806,000(L)6.96
28/08/2025Evodevo Ltd1213(L)-3,291,000(L)35,806,000(L)6.96
15/07/2025Cao Longxiang1316(L)68,493,150(L)68,493,150(L)13.31
15/07/2025Cao Fei1316(L)68,493,150(L)68,493,150(L)13.31
15/07/20251213(L)-94,493,150(L)96,678,571(L)18.79
15/07/2025Jiaze Global Capital Limited10031(L)68,493,150(L)68,493,150(L)13.31
15/07/2025China Resources Pharmaceutical Group Limited1213(L)-94,493,150(L)148,136,971(L)28.79
15/07/202510031(L)68,493,150(L)68,493,150(L)13.31
15/07/2025Tasly (Hong Kong) Pharmaceutical Investment Limited1213(L)-94,493,150(L)96,678,571(L)18.79
15/07/20251213(L)-94,493,150(L)96,678,571(L)18.79
15/07/20251316(L)68,493,150(L)68,493,150(L)13.31
15/07/20251316(L)68,493,150(L)68,493,150(L)13.31
15/07/2025China Resources Company Limited1213(L)-94,493,150(L)148,136,971(L)28.79
15/07/20251213(L)-94,493,150(L)96,678,571(L)18.79
27/03/2025Li Yunhui1213(L)0(L)0.00
27/03/20251711(L)0(L)0.00
27/03/20251711(L)0(L)0.00
27/03/20251711(L)0(L)0.00
27/03/2025Yan Xijun1213(L)0(L)0.00
27/03/2025Yan Kaijing1213(L)0(L)0.00
27/03/20251711(L)0(L)0.00
27/03/20251711(L)0(L)0.00
27/03/2025Wu Naifeng1213(L)0(L)0.00
 1   2   3  
Remark: (L) - Long Position, (S) - Short Position, (P) Lending;
  Real time quote last updated: 27/02/2026 18:00
  Real-time basic market prices of Hong Kong securities are provided by HKEx; a Designated Website authorized by the HKEx Group to provide the Service
A Member of HKET Holdings
Customer Service Hotline:(852) 2880 7004     Customer Service Email:cs@etnet.com.hk
Copyright 2026 ET Net Limited. http://www.etnet.com.hk ET Net Limited, HKEx Information Services Limited, its Holding Companies and/or any Subsidiaries of such holding companies, and Third Party Information Providers endeavour to ensure the availability, completeness, timeliness, accuracy and reliability of the information provided but do not guarantee its availability, completeness, timeliness, accuracy or reliability and accept no liability (whether in tort or contract or otherwise) any loss or damage arising directly or indirectly from any inaccuracies, interruption, incompleteness, delay, omissions, or any decision made or action taken by you or any third party in reliance upon the information provided. The quotes, charts, commentaries and buy/sell ratings on this website should be used as references only with your own discretion. ET Net Limited is not soliciting any subscriber or site visitor to execute any trade. Any trades executed following the commentaries and buy/sell ratings on this website are taken at your own risk for your own account.